HIC
AGN

Holderness Investments Company’s Allergan plc AGN Stock Holding History

Holderness Investments Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-963
Closed -$234K – 206
2017
Q2 		$234K Sell
963
-123
-11% -$28.9K 0.12% 176
2017
Q1 		$259K Buy
+1,086
New +$253K 0.13% 170

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Holderness Investments Company's AGN Position: Q3 2017 in Review

Holderness Investments Company sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 963 shares — an estimated $234K sold.

Holderness Investments Company first reported a position in AGN in Q1 2017 and held it in 2 quarters. The position peaked at $259K in Q1 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Holderness Investments Company reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Holderness Investments Company sold 963 Allergan plc shares in Q3 2017, an estimated $234K.
  • Holderness Investments Company first reported a position in Allergan plc in Q1 2017 and held it in 2 quarters.
  • Holderness Investments Company's Allergan plc position peaked at $259K in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Holderness Investments Company's 13F filing for Q3 2017, filed 9 Nov 2017.